Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PinnacleXon Nov 16, 2022 1:29pm
84 Views
Post# 35104067

RE:Hibernation

RE:Hibernation
SABBOBCAT wrote: Let's step back and think about when news may come. They are currently coming up on year end, so unless it is very material I wouldn't hold my breath for an update. Then we are I to the holiday season and tax loss selling. Strategically this would not be a good time if you are trying to kave a strong positive impact on the stock. Then there is January, where they are competing with a flurry of New Years headlines where companies are trying to get out in the news cycle, so again the reaction would be muted for a small player. So that leaves us with early Feb when they will need to announce their annual financials anyways. Barring some surprise, that is my best guess for news so it may be that we all need to hibernate this winter to protect our sanity haha


Like we've been hibernating the last 5 plus years?  This sewage that is this company has lower volume then when it first listed . You had FDA approval a supposedly very important news release with data Showing High Expression of Sortilin in Tumors etc, and the stock falls and falls and wont keep falling.  This company has ZERO money they have very little to no hope of what they think they have might work.  This is destruction of shareholder value and this is all theyve done. 
<< Previous
Bullboard Posts
Next >>